Results 281 to 290 of about 117,631 (302)

Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases

Pharmacological Research, 2016
Robert Roskoski
exaly  

Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3)

Bioorganic and Medicinal Chemistry Letters, 2007
Adam Golebiowski
exaly  

Janus Kinase

2011
openaire   +1 more source

Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature

Journal of Dermatological Treatment, 2017
Aniseh Samadi, Saman Ahmad Nasrollahi, Ashkan Hashemi   +2 more
exaly  

Janus Kinases

2008
openaire   +1 more source

Janus Kinases (JAK)

2012
Marissa K. Caldow, David Cameron-Smith
openaire   +1 more source

Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure

Journal of the American Academy of Dermatology, 2017
Lucy Y Liu, James P Strassner, Brett King   +2 more
exaly  

Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib

Journal of the American Academy of Dermatology, 2017
Brooke E Rothstein, Deep Joshipura, Yana Turkowski   +2 more
exaly  

Pharmacophore and docking-based virtual screening approach for the design of new dual inhibitors of Janus kinase 1 and Janus kinase 2

SAR and QSAR in Environmental Research, 2014
Haneesh Jasuja, Om Silakari
exaly  

Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects

Leukemia and Lymphoma, 2011
Ludovica Riera, Roberto Chiarle, A Pich   +2 more
exaly